Business

Illinois Pharmacists Can Prescribe PHEXXI Starting January 2026 Under Newly-passed Law

On August 15, 2025, Illinois enacted House Bill 3489, a measure designed to broaden access to contraception for its residents. This legislation permits pharmacists to prescribe a wider array of contraceptive options, including PHEXXI® (lactic acid, citric acid, and potassium bitartrate) , the hormone-free on-demand contraceptive vaginal gel from Evofem Biosciences (OTCID: EVFM). The law is slated to take effect on January 1, 2026.

articleEvofem Biosciences, Inc.August 21, 20256/company/evofem-biosciences-inc/news/illinois-pharmacists-can-prescribe-phexxi-starting-january-2026-under-newly-passed-law
Illinois Pharmacists Can Prescribe PHEXXI Starting January 2026 Under Newly-passed Law

About this update from Evofem Biosciences, Inc.

[{"type":"text","content":"-- Passage of House Bill 3489 allows Illinois pharmacists to prescribe non-hormonal and emergency contraceptives --","length":115,"tagName":"p","attribs":{}},{"type":"text","content":"-- Ensures a broader range of contraceptive choices is available to women state-wide --","length":87,"tagName":"p","attribs":{}},{"type":"text","content":"SAN DIEGO, Aug. 21, 2025 /PRNewswire/ -- On August 15, 2025, Illinois enacted House Bill 3489, a measure designed to broaden access to contraception for its residents. This legislation permits pharmacists to prescribe a wider array of contraceptive options, including PHEXXI® (lactic acid, citric acid, and potassium bitartrate) , the hormone-free on-demand contraceptive vaginal gel from Evofem Biosciences (OTCID: EVFM). The law is slated to take effect on January 1, 2026.","length":480,"tagName":"p"},{"type":"image","alt":"Women's health innovator Evofem Biosciences (OTCQB: EVFM) (PRNewsfoto/Evofem Biosciences, Inc.)","displaySize":"","headline":null,"caption":"Women's health innovator Evofem Biosciences (OTCQB: EVFM) (PRNewsfoto/Evofem Biosciences, Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":209,"url":"https://media.zenfs.com/en/prnewswire.com/b0b393f2cbffee7b6c52a7dea7c44bd2"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/s3aOPVcdo91_a65mo20iIg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM2ODtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/b0b393f2cbffee7b6c52a7dea7c44bd2","width":400,"height":209}},"href":"https://mma.prnewswire.com/media/780907/Evofem_Biosciences_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":""The newly ratified House Bill 3489 addresses a critical need by empowering pharmacists across Illinois to prescribe a full range of contraceptive options while expanding access to non-hormonal choices like PHEXXI, ensuring women have timely access to the methods that best suit their individual health needs and preferences," said Saundra Pelletier, Evofem's CEO.","length":378,"tagName":"p"},{"type":"text","content":"The enactment of this new law marks considerable progress for Illinois in its efforts to improve residents' access to a broader range of FDA-approved contraceptive choices. This law expands the options that pharmacists in Illinois can offer to include non-hormonal and emerge...

More updates from Evofem Biosciences, Inc.

potassium bitartrateIllinoisEvofem BiosciencesIllinois State Representativehormonal methodscitric acidlactic acidcontraceptive optionspharmacistsThe Companyhealthcare provider